[go: up one dir, main page]

YU41500A - Novi makrolidi - Google Patents

Novi makrolidi

Info

Publication number
YU41500A
YU41500A YU41500A YU41500A YU41500A YU 41500 A YU41500 A YU 41500A YU 41500 A YU41500 A YU 41500A YU 41500 A YU41500 A YU 41500A YU 41500 A YU41500 A YU 41500A
Authority
YU
Yugoslavia
Prior art keywords
compounds
relates
novel
methods
protozoa infections
Prior art date
Application number
YU41500A
Other languages
English (en)
Inventor
John Philip Dirlam
Hamish Alastair Mcarthur
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU41500A publication Critical patent/YU41500A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Pronalazak se odnosi na nove analoge i azalide eritromicina, posebno na one sa novim C-13 supstituentima, i na njihove farmaceutski prihvatljive soli. Jedinjenja prema ovom pronalasku su protivbakterijska sredstva koja se mogu koristiti za lečenje raznih bakterijskih infekcija i infekcija protozoama. Pronalazak se takodje odnosi na farmaceutske kompozicije koje sadrže ta jedinjenja i na postupke za lečenje bakterijskih infekcija i infekcija protozoama davanjem tih jedinjenja. Pronalazak se takodje odnosi na postupke za pripremanje ovih jedinjenja i na medjuproizvode korisne kod tih pripremanja.[The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C- 13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
YU41500A 1998-01-02 1998-12-21 Novi makrolidi YU41500A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7034398P 1998-01-02 1998-01-02

Publications (1)

Publication Number Publication Date
YU41500A true YU41500A (sh) 2003-02-28

Family

ID=22094723

Family Applications (1)

Application Number Title Priority Date Filing Date
YU41500A YU41500A (sh) 1998-01-02 1998-12-21 Novi makrolidi

Country Status (34)

Country Link
US (2) US6472371B1 (sh)
EP (1) EP1044207A1 (sh)
JP (1) JP2002500230A (sh)
KR (1) KR100352809B1 (sh)
CN (1) CN1284081A (sh)
AP (1) AP9801420A0 (sh)
AR (4) AR014948A1 (sh)
AU (1) AU756409B2 (sh)
BG (1) BG104644A (sh)
BR (1) BR9814601A (sh)
CA (1) CA2316919C (sh)
CO (1) CO4970821A1 (sh)
CZ (1) CZ20002458A3 (sh)
DZ (1) DZ2698A1 (sh)
EA (1) EA200000594A1 (sh)
GT (1) GT199800206A (sh)
HR (1) HRP20000442A2 (sh)
HU (1) HUP0100420A3 (sh)
IL (1) IL137024A0 (sh)
IS (1) IS5528A (sh)
MA (1) MA24729A1 (sh)
NO (1) NO20003347L (sh)
NZ (1) NZ504986A (sh)
OA (1) OA11438A (sh)
PA (1) PA8465301A1 (sh)
PE (1) PE20000049A1 (sh)
PL (1) PL341642A1 (sh)
SK (1) SK9782000A3 (sh)
TN (1) TNSN98238A1 (sh)
TW (1) TW520374B (sh)
UY (2) UY25330A1 (sh)
WO (1) WO1999035156A1 (sh)
YU (1) YU41500A (sh)
ZA (1) ZA9811939B (sh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
EP1754700A3 (en) 1999-01-27 2007-05-09 Kosan Biosciences, Inc. Synthesis of oligoketides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
CA2370743A1 (en) 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
CZ20013733A3 (cs) 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
EP1479687A4 (en) * 2002-02-26 2006-01-04 Meiji Seika Kaisha A NEW LOW-GYLIC CYCLIC AZALIDE, A NEW 16-LOW CYCLIC DIAZALID DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF
ATE406348T1 (de) 2004-09-23 2008-09-15 Schering Plough Ltd Bekämpfung von parasiten in tieren durch verwendung neuer trifluormethansulfonanilidoximetherderivate
MX2007006072A (es) * 2004-11-19 2007-07-11 Schering Plough Ltd Control de parasitos en animales mediante el uso de derivados del parasiticida 2-fenil-3-(1h-pirrol-2-il)acrilonitrilo.
UA85937C2 (uk) 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
AR054380A1 (es) * 2005-06-09 2007-06-20 Schering Plough Ltd Control de parasitos en animales con derivados de n- ((feniloxi) fenil) -1,1,1-trifluorometansulfonamida y de n-(fenilsulfanil) fenil) -1,1,1-trifluorometansulfonamida
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
US8044230B2 (en) * 2006-12-13 2011-10-25 Intervet Inc. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
WO2008076259A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2666187T3 (es) 2007-06-27 2018-05-03 E. I. Du Pont De Nemours And Company Procedimiento de control de plagas en animales
WO2009064953A1 (en) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
TWI468407B (zh) 2008-02-06 2015-01-11 Du Pont 中離子農藥
EP2321269B1 (en) * 2008-07-30 2018-09-19 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
KR20120047996A (ko) 2009-08-05 2012-05-14 이 아이 듀폰 디 네모아 앤드 캄파니 메소이온성 살충제
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
BR112012002519A2 (pt) 2009-08-05 2019-09-24 Du Pont "pesticidas mesoiônicos"
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
JP5933530B2 (ja) 2010-05-27 2016-06-08 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ ４−［５−［３−クロロ−５−（トリフルオロメチル）フェニル］−４，５−ジヒドロ−５−（トリフルオロメチル）−３−イソオキサゾリル］−ｎ−［２−オキソ−２−［（２，２，２−トリフルオロエチル）アミノ］エチル］−１−ナフタレンカルボキサミドの結晶質形態
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
WO2012105562A1 (ja) * 2011-01-31 2012-08-09 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規マクロライド誘導体
MX2013014326A (es) 2011-06-20 2014-01-23 Du Pont Compuestos heterociclicos para tratar infecciones por helmintos.
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
JP2015502936A (ja) 2011-11-28 2015-01-29 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ スルホンアミド駆虫薬
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
US3923784A (en) 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4585759A (en) 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
HU198913B (en) 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
US5141926A (en) 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US5985844A (en) 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2065218A1 (en) 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US6162794A (en) 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AU7961498A (en) 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
DK0941998T3 (da) 1998-03-03 2004-09-20 Pfizer Prod Inc 3,6-ketalmakrolidantibiotika
US6248719B1 (en) 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
US6043227A (en) 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
ID28286A (id) 1998-11-03 2001-05-10 Pfizer Prod Inc Antibiotik-antibiotik makrolida baru
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
CZ20013733A3 (cs) 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
JP4311203B2 (ja) 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法

Also Published As

Publication number Publication date
TNSN98238A1 (fr) 2005-03-15
AR020551A2 (es) 2002-05-15
CO4970821A1 (es) 2000-11-07
AR019787A2 (es) 2002-03-13
CN1284081A (zh) 2001-02-14
HRP20000442A2 (en) 2001-04-30
KR100352809B1 (ko) 2002-11-01
AR020851A2 (es) 2002-05-29
WO1999035156B1 (en) 1999-10-21
SK9782000A3 (en) 2001-12-03
WO1999035156A1 (en) 1999-07-15
HUP0100420A2 (hu) 2001-07-30
US20040092459A1 (en) 2004-05-13
CA2316919A1 (en) 1999-07-15
BR9814601A (pt) 2000-10-17
AR014948A1 (es) 2001-04-11
PA8465301A1 (es) 2000-09-29
UY25574A1 (es) 1999-09-27
MA24729A1 (fr) 1999-07-01
EA200000594A1 (ru) 2001-04-23
NO20003347D0 (no) 2000-06-27
KR20010024818A (ko) 2001-03-26
NO20003347L (no) 2000-08-28
US6472371B1 (en) 2002-10-29
NZ504986A (en) 2003-03-28
AP9801420A0 (en) 1998-12-31
OA11438A (en) 2004-04-30
HUP0100420A3 (en) 2003-07-28
BG104644A (en) 2001-01-31
CA2316919C (en) 2004-10-26
UY25330A1 (es) 2000-12-29
JP2002500230A (ja) 2002-01-08
CZ20002458A3 (cs) 2001-10-17
EP1044207A1 (en) 2000-10-18
US7015203B2 (en) 2006-03-21
ZA9811939B (en) 2000-06-30
DZ2698A1 (fr) 2003-03-29
GT199800206A (es) 2000-06-21
AU1444799A (en) 1999-07-26
PL341642A1 (en) 2001-04-23
TW520374B (en) 2003-02-11
IL137024A0 (en) 2001-06-14
PE20000049A1 (es) 2000-02-07
IS5528A (is) 2000-06-09
AU756409B2 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
YU41500A (sh) Novi makrolidi
UA70298A (uk) Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції
CA2292359A1 (en) Novel azalides and methods of making same
YU40900A (sh) Novi derivati eritromicina
AP2001002142A0 (en) 13-membered azalides and their use as antibiotic agents.
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
AP2001002222A0 (en) Ketolide antibiotics.
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
AP2001002131A0 (en) Novel macrolide antibiotics.
ATE344269T1 (de) Carbamat und carbazat ketolid antibiotika
BR9903737A (pt) Carbamatos em c-11 de macrólidos antibacterianos
AP9801377A0 (en) Tricyclic erythromycin derivatives.
EP1114826A3 (en) Novel antibacterial and prokinetic macrolides
CA2332686A1 (en) Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates
AP9801235A0 (en) Erythromycin derivatives.
YU64300A (sh) Derivati 2"-deoksi higromicina